Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04978935
Other study ID # MersinUniversityNursingFaculty
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 28, 2021
Est. completion date December 30, 2022

Study information

Verified date July 2021
Source Mersin University
Contact DILARA SOYDAN, Master
Phone 03243610001
Email dilarasoydan@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized controlled trial evaluates the effect of the care protocol, which consists of independent nursing interventions, which play an important role in accelerating the recovery process of the patient, such as the patient's position, mobilization, use of spirometry, and providing shoulder exercises after thoracotomy. The hypothesis of this research is; the care protocol applied to the patients after thoracotomy has an effect on the patients' pulmonary function tests (FVC, FEV1, FEV1/FVC) and on the mobilization of the patients, the development of complications, the time of chest tube removal and the discharge


Description:

Methods: In the study, 80 patients were randomly assigned to the study and control groups. Nursing interventions will be applied to the patients included in the study group (n=40), starting from the 0th day (the first day spent in the intensive care unit) after the thoracotomy in line with the prepared care protocol application steps until discharge. maintenance protocol; It will consist of position of the patient, mobilization, use of spirometer and shoulder exercises. The primary outcome of the research is the effect of the maintenance protocol used in the improvement of respiratory function on respiratory function tests. The secondary outcome of the research is to determine the effect of the care protocol on mobilization, complication development status, chest tube removal and discharge time in patients. The results are obtained by recording PFT values on the 1st, 5th and discharge days before and after thoracotomy. Postoperative (0.,1.,2.,3.,4.,5.) days and discharge day; mobilization, complication development status, chest tube removal time and discharge date will be recorded on the Patient Results Form.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date December 30, 2022
Est. primary completion date August 28, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Accepting to participate in the research, - 18 years and older, - Conscious, oriented and cooperative, - Able to speak and understand Turkish, - Does not have any psychiatric disease, - Elective thoracotomy performed, - Chest tube inserted, - Patients who were followed up in the intensive care unit on the first day after surgery and admitted to the clinic the next day - Patients without a history of metastatic disease Exclusion Criteria: - Those who do not accepted to participate in the research, - Under 18 years of age, - Unconscious, without orientation and cooperation, - Who cannot speak or understand Turkish, - Having a psychiatric problem, - Non thoracotomy - Non chest tube, - Metastatic disease, - Emergency thoracotomy applied, - Patients staying in the intensive care unit for more than one day.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Care protocol
Before starting the application, the investigator (DS) will fill out the Introductory Characteristics Form of all patients, the Pre-thoracotomy Pulmonary Function Test (PFT) section of the Patient Results Form. The PFT section will be re-evaluated on the 1st, 5th day and on the day of discharge after thoracotomy. Nursing interventions will be applied to the study group (n=40), starting from the 0th day (the first day spent in the intensive care unit) after the thoracotomy in line with the prepared care protocol application steps until discharge. Care protocol consists of patient's position, mobilization, use of spirometer and shoulder exercises.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mersin University

Outcome

Type Measure Description Time frame Safety issue
Primary Pulmonary function test values evaluated using the care protocol Pulmonary function tests. Pulmonary function tests will be measured with a portable pulmonary function tester. In the evaluation, FVC (%), FEV1 (%) and FEV1/FVC (%) parameters will be used Change from before implementation preoperative and postoperative (1.,5.) days and an average of 2 weeks
Secondary Mobilization evaluated using the care protocol In the study, the patient's in-bed and out-of-bed mobilization will be provided by considering the mobilization application steps, and the patient will be asked to stay out of bed for two hours on the 0 th day after surgery. In the clinic, the patient will be mobilized in line with the mobilization application steps. The patient will be asked to stay out of bed for six hours from the first postoperative day until discharge. The steps taken will be recorded with the pedometer Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks
Secondary Prevention of complications evaluated using the care protocol After the thoracotomy, the conditions that the doctor considers as complications (atelectasis, pneumonia, air leak, bronchospasm, subcutaneous emphysema, atrial fibrillation) will be recorded and daily evaluation will be made. Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks
Secondary Chest tube removal evaluated using the care protocol The time of chest tube removal and the day will be recorded in the Patient Results Form Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks
Secondary Discharge time evaluated using the care protocol The time of discharge will be recorded in the Patient Results Form Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04549935 - The PRIME Study: A Randomized, Controlled, Prospective Study Phase 4
Active, not recruiting NCT06064045 - Using Simulation to Support Staff and Improve Quality of Treatment: An Intervention Project Within Pediatrics N/A